Carotid Artery Wall Thickness and Leukoaraiosis: Preliminary Results Using Multidetector Row CT Angiography

References

1. 1.↵
   1. Hachinski VC,
   2. Potter P,
   3. Merskey H

   . Leuko-araiosis. Arch Neurol 1987;44:21–23

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Ovbiagele B,
   2. Saver JL

   . Cerebral white matter hyperintensities on MRI: current concepts and therapeutic implications. Cerebrovasc Dis 2006;22:83–90

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Pantoni L,
   2. Garcia JH

   . The significance of cerebral white matter abnormalities 100 years after Binswanger's report: a review. Stroke 1995;26:1293–301

   Abstract/FREE Full Text
4. 4.↵
   1. Ylikoski A,
   2. Erkinjuntti T,
   3. Raininko R,
   4. et al

   . White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995;26:1171–77

   Abstract/FREE Full Text
5. 5.↵
   1. Madureira S,
   2. Verdelho A,
   3. Moleiro C,
   4. et al

   . Neuropsychological predictors of dementia in a three-year follow-up period: data from the LADIS study. Dement Geriatr Cogn Disord 2010;29:325–34

   CrossRefPubMed
6. 6.↵
   1. Teodorczuk A,
   2. Firbank MJ,
   3. Pantoni L,
   4. et al

   . Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 2010;40:603–10

   CrossRefPubMed
7. 7.↵
   1. Henon H,
   2. Vroylandt P,
   3. Durieu I,
   4. et al

   . Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 2003;34:2935–40

   Abstract/FREE Full Text
8. 8.↵
   1. Streifler JY,
   2. Eliasziw M,
   3. Benavente OR

   . Development and progression of leukoaraiosis in patients with brain ischemia and carotid artery disease. Stroke 2003;34:1913–16

   Abstract/FREE Full Text
9. 9.↵
   1. Auriel E,
   2. Bornstien NM,
   3. Berenyi E,
   4. et al

   . Clinical, radiological and pathological correlates of leukoaraiosis. Acta Neurol Scand 2011;123:41–47

   CrossRefPubMed
10. 10.↵
    1. Pantoni L,
    2. Garcia JH

    . Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652–59

    Abstract/FREE Full Text
11. 11.↵
    1. Saba L,
    2. Sanfilippo R,
    3. Pascalis L,
    4. et al

    . Carotid artery abnormalities and leukoaraiosis in elderly patients: evaluation with MDCT. AJR Am J Roentgenol 2009;192:W63–70
12. 12.↵
    1. de Leeuw FE,
    2. de Groot JC,
    3. Bots ML

    . Carotid atherosclerosis and cerebral white matter lesions in a population-based magnetic resonance imaging study. J Neurol 2000;247:291–96

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Waterston JA,
    2. Brown MM,
    3. Butler P,
    4. et al

    . Small deep cerebral infarcts associated with occlusive internal carotid artery disease: a hemodynamic phenomenon? Arch Neurol 1990;47:953–57

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Saba L,
    2. Sanfilippo R,
    3. Montisci R,
    4. et al

    . Correlation between US-PSV and MDCTA in the quantification of carotid artery stenosis. Eur J Radiol 2010;74:99–103

    CrossRefPubMed
15. 15.↵
    1. Xiong L,
    2. Deng YB,
    3. Zhu Y,
    4. et al

    . Correlation of carotid plaque neovascularization detected by using contrast-enhanced US with clinical symptoms. Radiology 2009;251:583–89

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Jaff MR,
    2. Goldmakher GV,
    3. Lev MH,
    4. et al

    . Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography. Vasc Med 2008;13:281–92

    Abstract/FREE Full Text
17. 17.↵
    1. Ward RP,
    2. Lammertin G,
    3. Virnich DE,
    4. et al

    . Use of carotid intima-media thickness to identify patients with ischemic stroke and transient ischemic attack with low yield of cardiovascular sources of embolus on transesophageal echocardiography. Stroke 2008;39:2969–74

    Abstract/FREE Full Text
18. 18.↵
    1. Talelli P,
    2. Terzis G,
    3. Katsoulas G,
    4. et al

    . Recurrent stroke: the role of common carotid artery intima-media thickness. J Clin Neurosci 2007;14:1067–72

    CrossRefPubMed
19. 19.↵
    1. Tsivgoulis G,
    2. Vemmos K,
    3. Papamichael C,
    4. et al

    . Common carotid artery intima-media thickness and the risk of stroke recurrence. Stroke 2006;37:1913–16

    Abstract/FREE Full Text
20. 20.↵
    1. Heeringa J,
    2. van der Kuip DA,
    3. Hofman A,
    4. et al

    . Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med 2007;167:382–87

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Saba L,
    2. Sanfilippo R,
    3. Pascalis L,
    4. et al

    . Carotid artery wall thickness and ischemic symptoms: evaluation using multi-detector-row CT angiography. Eur Radiol 2008;18:1962–71

    CrossRefPubMed
22. 22.↵
    1. Saba L,
    2. Sanfilippo R,
    3. Montisci R,
    4. et al

    . Carotid artery wall thickness: comparison between sonography and multi-detector row CT angiography. Neuroradiology 2010;52:75–82

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Fanning NF,
    2. Walters TD,
    3. Fox AJ,
    4. et al

    . Association between calcification of the cervical carotid artery bifurcation and white matter ischemia. AJNR Am J Neuroradiol 2006;27:378–83

    Abstract/FREE Full Text
24. 24.↵
    1. Saba L,
    2. Mallaring G

    . MDCTA of carotid plaque degree of stenosis: evaluation of interobserver agreement. AJR Am J Roentgenol 2008;190:W41–46

    CrossRef
25. 25.↵
    1. Saba L,
    2. Mallarini G

    . Window settings for the study of calcified carotid plaques with multidetector CT angiography. AJNR Am J Neuroradiol 2009;30:1445–50

    Abstract/FREE Full Text
26. 26.↵
    1. Fox AJ

    . How to measure carotid stenosis. Radiology 1993;186:316–18

    PubMedWeb of Science
27. 27.↵
    1. Morgenstern LB,
    2. Fox AJ,
    3. Sharpe BL,
    4. et al

    . The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery: North American Symptomatic Carotid Endarterectomy Trial (NASCET) group. Neurology 1997;48:911–15

    Abstract/FREE Full Text
28. 28.↵
    1. Fox AJ,
    2. Eliasziw M,
    3. Rothwell PM,
    4. et al

    . Identification, prognosis, and management of patients with carotid artery near occlusion. AJNR Am J Neuroradiol 2005;26:2086–94

    Abstract/FREE Full Text
29. 29.↵
    1. Ebrahim S,
    2. Papacosta O,
    3. Whincup P,
    4. et al

    . Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study Stroke 1999;30:841–50

    Abstract/FREE Full Text
30. 30.↵
    1. de Weert TT,
    2. Ouhlous M,
    3. Meijering E,
    4. et al

    . In vivo characterization and quantification of atherosclerotic carotid plaque components with multidetector computed tomography and histopathological correlation. Arterioscler Thromb Vasc Biol 2006;26:2366–72

    Abstract/FREE Full Text
31. 31.↵
    1. de Weert TT,
    2. Ouhlous M,
    3. Zondervan PE,
    4. et al

    . In vitro characterization of atherosclerotic carotid plaque with multidetector computed tomography and histopathological correlation. Eur Radiol 2005;15:1906–14

    CrossRefPubMed
32. 32.↵
    1. de Weert TT,
    2. de Monyé C,
    3. Meijering E,
    4. et al

    . Assessment of atherosclerotic carotid plaque volume with multidetector computed tomography angiography. Int J Cardiovasc Imaging 2008;24:751–59

    CrossRefPubMed
33. 33.↵
    1. Wahlund LO,
    2. Barkhof F,
    3. Fazekas F,
    4. et al

    . European Task Force in Age-Related White Matter Changes: a new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318–22

    Abstract/FREE Full Text
34. 34.↵
    1. Landis JR,
    2. Koch GG

    . The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Kuller LH,
    2. Longstreth WT,
    3. Arnold AM,
    4. et al

    . White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004;35:1821–25

    Abstract/FREE Full Text
36. 36.↵
    1. Pantoni L,
    2. Simoni M,
    3. Pracucci G,
    4. et al

    . Visual rating scales for age-related white matter changes (leukoaraiosis): can the heterogeneity be reduced? Stroke 2002;33:2827–33

    Abstract/FREE Full Text
37. 37.↵
    1. Pantoni L

    . Pathophysiology of age-related cerebral white matter changes. Cerebrovasc Dis 2002;13:7–10
38. 38.↵
    1. Brown WR,
    2. Moody DM,
    3. Thore CR,
    4. et al

    . Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis Ann N Y Acad Sci 2000;903:39–45

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Moody DM,
    2. Brown WR,
    3. Challa VR,
    4. et al

    . Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann N Y Acad Sci 1997;826–103-16

    PubMedWeb of Science
40. 40.↵
    1. Brown WR,
    2. Moody DM,
    3. Thore CR,
    4. et al

    . Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci 2007;257:62–66. Epub 2007 Feb 23

    CrossRefPubMed
41. 41.↵
    1. Moody DM,
    2. Thore CR,
    3. Anstrom JA,
    4. et al

    . Quantification of afferent vessels shows reduced brain vascular density in subjects with leukoaraiosis. Radiology 2004;223:883–90
42. 42.↵
    1. Conde JR,
    2. Streit WJ

    . Microglia in the aging brain. J Neuropathol Exp Neurol 2006;65:199–203

    PubMedWeb of Science
43. 43.↵
    1. Ball MJ

    . Leukoaraiosis explained. Lancet 1989;8638:612–13
44. 44.↵
    1. Mirsen TR,
    2. Lee DH,
    3. Wong CJ,
    4. et al

    . Clinical correlates of white matter changes on magnetic resonance imaging scans of the brain. Arch Neurol 1991;48:1015–21

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Davis PH,
    2. Dawson JD,
    3. Riley WA,
    4. et al

    . Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine study. Circulation 2001;104:2815–19

    Abstract/FREE Full Text
46. 46.↵
    1. Simon A,
    2. Gariepy J,
    3. Chironi G,
    4. et al

    . Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002;20:159–69

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Manolio TA,
    2. Burke GL,
    3. O'Leary DH,
    4. et al

    . Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999;19:356–65

    Abstract/FREE Full Text
48. 48.↵
    1. Tanaka T,
    2. Shimizu T,
    3. Fukuhara T

    . The relationship between leukoaraiosis volume and parameters of carotid artery duplex ultrasonographic scanning in asymptomatic diabetic patients. Comput Med Imaging Graph 2009;33:489–93

    CrossRefPubMed
49. 49.↵
    1. Manolio TA,
    2. Kronmal RA,
    3. Burke GL,
    4. et al

    . Magnetic resonance abnormalities and cardiovascular disease in older adults: the Cardiovascular Health Study. Stroke 1994;25:318–27

    Abstract/FREE Full Text
50. 50.↵
    1. Schmidt R,
    2. Petrovic K,
    3. Ropele S,
    4. et al

    . Progression of leukoaraiosis and cognition. Stroke 2007;38:2619–25

    Abstract/FREE Full Text
51. 51.↵
    1. Liao D,
    2. Cooper L,
    3. Cai J,
    4. et al

    . Presence and severity of cerebral white matter lesions and hypertension, its treatment and its control: the ARIC study—Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262–70

    Abstract/FREE Full Text
52. 52.↵
    1. Schmidt R,
    2. Fazekas F,
    3. Offenbacher H,
    4. et al

    . Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 1991;48:417–20

    CrossRefPubMedWeb of Science
53. 53.↵
    1. Kertesz A,
    2. Black SE,
    3. Tokar G,
    4. et al

    . Periventricular and subcortical hyperintensities on magnetic resonance imaging: “rims, caps, and unidentified bright objects.” Arch Neurol 1988;45:404–08

    CrossRefPubMedWeb of Science
54. 54.↵
    1. Awad IA,
    2. Spetzler RF,
    3. Hodak JA,
    4. et al

    . Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with cerebrovascular risk factors. Stroke 1986;17:1084–89

    Abstract/FREE Full Text
55. 55.↵
    1. George AE,
    2. de Leon MJ,
    3. Gentes CI,
    4. et al

    . Leukoencephalopathy in normal and pathologic aging. I. CT of brain lucencies. AJNR Am J Neuroradiol 1986;7:561–66
56. 56.↵
    1. Murray AD,
    2. Staff RT,
    3. Shenkin SD,
    4. et al

    . Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Radiology 2005;237:251–57

    CrossRefPubMedWeb of Science
57. 57.↵
    1. Khan U,
    2. Porteous L,
    3. Hassan A,
    4. et al

    . Risk factor profile of cerebral small vessel disease and its subtypes. J Neurol Neurosurg Psychiatry 2007;78:702–06

    Abstract/FREE Full Text
58. 58.↵
    1. Ouhlous M,
    2. Flach Z,
    3. de Weert TT,
    4. et al

    . Carotid plaque composition and cerebral infarction: MR imaging study. AJNR Am J Neuroradiol 2005;26:1044–49

    Abstract/FREE Full Text
59. 59.↵
    1. Altaf N,
    2. Morgan PS,
    3. Moody A,
    4. et al

    . Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage. Radiology 2008;248:202–09

    CrossRefPubMedWeb of Science